• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巢式聚合酶链反应基因分型在丙型肝炎病毒和人类免疫缺陷病毒合并感染患者中的诊断结果差异。

Discrepant Diagnostic Results of Nested Polymerase Chain Reaction-based Genotyping in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.

机构信息

Department of Gastroenterology, Toyama University Hospital, Japan.

Department of Community Medical Support, Toyama University Hospital, Japan.

出版信息

Intern Med. 2021 Oct 15;60(20):3239-3243. doi: 10.2169/internalmedicine.7132-21. Epub 2021 Apr 26.

DOI:10.2169/internalmedicine.7132-21
PMID:33896867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8580760/
Abstract

Accurate genotyping is important to improve the treatment of hepatitis C virus (HCV) infection. We herein report a 44-year-old Japanese man with hemophilia A and coinfection of HCV and human immunodeficiency virus (HIV) who was diagnosed with HCV genotype 4 by direct sequencing. Two genotyping tests based on the nested polymerase chain reaction method that we used misdiagnosed his genotype as 2b and 1b. Although several HCV genotyping tests are available in Japan, it is important to recognize that some cannot detect genotype 4. Care should be taken when genotyping HCV patients who have received non-heated coagulation factor preparations or were infected abroad.

摘要

准确的基因分型对于改善丙型肝炎病毒(HCV)感染的治疗至关重要。我们在此报告一例 44 岁的日本男性,患有血友病 A 和 HCV 与人类免疫缺陷病毒(HIV)合并感染,通过直接测序诊断为 HCV 基因型 4。我们使用的基于巢式聚合酶链反应方法的两种基因分型检测错误地将其基因型诊断为 2b 和 1b。尽管日本有几种 HCV 基因分型检测方法,但重要的是要认识到有些方法可能无法检测到基因型 4。对于那些接受过未加热的凝血因子制剂或在国外感染的 HCV 患者进行基因分型时应谨慎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f5/8580760/12c530309cfc/1349-7235-60-3239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f5/8580760/0b3b91c099a1/1349-7235-60-3239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f5/8580760/960f7cb8ed18/1349-7235-60-3239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f5/8580760/12c530309cfc/1349-7235-60-3239-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f5/8580760/0b3b91c099a1/1349-7235-60-3239-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f5/8580760/960f7cb8ed18/1349-7235-60-3239-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f5/8580760/12c530309cfc/1349-7235-60-3239-g003.jpg

相似文献

1
Discrepant Diagnostic Results of Nested Polymerase Chain Reaction-based Genotyping in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.巢式聚合酶链反应基因分型在丙型肝炎病毒和人类免疫缺陷病毒合并感染患者中的诊断结果差异。
Intern Med. 2021 Oct 15;60(20):3239-3243. doi: 10.2169/internalmedicine.7132-21. Epub 2021 Apr 26.
2
Presence of different hepatitis C virus genotypes in plasma and peripheral blood mononuclear cell samples of Iranian patients with HIV infection.伊朗 HIV 感染患者血浆和外周血单个核细胞样本中不同丙型肝炎病毒基因型的存在。
J Med Virol. 2018 Aug;90(8):1343-1351. doi: 10.1002/jmv.24925. Epub 2018 Apr 23.
3
Spontaneous clearance of hepatitis C virus in a patient co-infected with hepatitis C virus and human immunodeficiency virus: a case report.丙型肝炎病毒与人类免疫缺陷病毒合并感染患者丙型肝炎病毒的自发清除:一例报告
J Gastrointestin Liver Dis. 2014 Sep;23(3):325-7. doi: 10.15403/jgld.2014.1121.233.auk.
4
Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.伊朗人类免疫缺陷病毒感染患者隐匿性丙型肝炎病毒感染的流行率。
J Med Virol. 2016 Nov;88(11):1960-6. doi: 10.1002/jmv.24474. Epub 2016 Jul 27.
5
[Prevalence and genotype distribution changes in hepatitis C virus co-infection among human immunodeficiency virus-infected patients].[人类免疫缺陷病毒感染患者中丙型肝炎病毒合并感染的患病率及基因型分布变化]
Enferm Infecc Microbiol Clin. 2015 Feb;33(2):110-2. doi: 10.1016/j.eimc.2014.05.010. Epub 2014 Dec 12.
6
TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.TM6SF2 E167K变异体可预测人类免疫缺陷病毒/丙型肝炎病毒合并感染患者的严重肝纤维化,且仅对非3型丙型肝炎病毒基因型患者预测严重脂肪变性。
World J Gastroenterol. 2016 Oct 14;22(38):8509-8518. doi: 10.3748/wjg.v22.i38.8509.
7
Evaluation and treatment of hepatitis C in patients with human immunodeficiency virus.人类免疫缺陷病毒感染者丙型肝炎的评估与治疗
South Med J. 2012 Oct;105(10):500-3. doi: 10.1097/SMJ.0b013e3182675d86.
8
Hepatitis C virus infection and genotypes in Japanese hemophiliacs.日本血友病患者中的丙型肝炎病毒感染及基因型
Liver. 1995 Jun;15(3):131-4. doi: 10.1111/j.1600-0676.1995.tb00659.x.
9
Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.丙型肝炎血浆病毒载量与丙肝病毒基因型有关,但与合并感染艾滋病毒无关。
J Med Virol. 1996 Apr;48(4):339-43. doi: 10.1002/(SICI)1096-9071(199604)48:4<339::AID-JMV7>3.0.CO;2-8.
10
Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections.法国血友病患者中的丙型肝炎病毒基因型:混合感染的动力学及重新评估
J Med Virol. 1997 Jan;51(1):36-41. doi: 10.1002/(sici)1096-9071(199701)51:1<36::aid-jmv6>3.0.co;2-t.

引用本文的文献

1
Successful treatment of Japanese hemophilia patient co-infected with HIV and HCV genotype 4a by glecaprevir/pibrentasvir therapy.成功治疗日本血友病患者合并 HIV 和 HCV 基因型 4a 的药物:glecaprevir/pibrentasvir 疗法。
Clin J Gastroenterol. 2021 Dec;14(6):1725-1732. doi: 10.1007/s12328-021-01524-1. Epub 2021 Oct 19.

本文引用的文献

1
EASL Recommendations on Treatment of Hepatitis C 2018.2018年欧洲肝脏研究学会丙型肝炎治疗推荐意见
J Hepatol. 2018 Aug;69(2):461-511. doi: 10.1016/j.jhep.2018.03.026. Epub 2018 Apr 9.
2
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis.Glecaprevir/Pibrentasvir 治疗 8 或 12 周对无肝硬化的 2、4、5 或 6 型丙型肝炎病毒感染患者的疗效。
Clin Gastroenterol Hepatol. 2018 Mar;16(3):417-426. doi: 10.1016/j.cgh.2017.09.027. Epub 2017 Sep 22.
3
Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.
丙型肝炎病毒引起的慢性肝炎因基因间2b/1b重组导致血清群与基因型不一致:直接抗病毒药物抗病毒治疗中的一个陷阱
Hepatol Res. 2018 Feb;48(3):E372-E378. doi: 10.1111/hepr.12977. Epub 2017 Sep 25.
4
Identification of Genotype 2 HCV in Serotype-1 Hepatitis C Patients Unresponsive to Daclatasvir plus Asunaprevir Treatment.对达卡他韦联合阿苏那普韦治疗无反应的1型丙型肝炎患者中2型丙型肝炎病毒基因型的鉴定
Tohoku J Exp Med. 2017 Jan;241(1):21-28. doi: 10.1620/tjem.241.21.
5
Management of hepatitis C genotype 4 in the directly acting antivirals era.直接抗病毒药物时代丙型肝炎基因4型的管理
BMJ Open Gastroenterol. 2016 Sep 30;3(1):e000112. doi: 10.1136/bmjgast-2016-000112. eCollection 2016.
6
Non-response to daclatasvir and asunaprevir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2.丙型肝炎病毒1型和2型合并感染患者对达卡他韦和阿舒瑞韦治疗无应答。
Hepatol Res. 2017 Mar;47(4):364-367. doi: 10.1111/hepr.12758. Epub 2016 Aug 26.
7
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.来迪派韦和索磷布韦用于治疗合并感染HIV-1的丙型肝炎病毒患者。
N Engl J Med. 2015 Aug 20;373(8):705-13. doi: 10.1056/NEJMoa1501315. Epub 2015 Jul 21.
8
Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.来迪派韦和索磷布韦治疗丙型肝炎基因4型:一项概念验证性、单中心、开放标签的2a期队列研究。
Lancet Infect Dis. 2015 Sep;15(9):1049-1054. doi: 10.1016/S1473-3099(15)00157-7. Epub 2015 Jul 14.
9
Discrepant diagnostic results using two genotyping methods in a chronic hepatitis C patient in serogroup 1.在一位丙型肝炎患者(血清型 1)中,两种基因分型方法的诊断结果不一致。
Hepatol Res. 2016 Apr;46(4):354-6. doi: 10.1111/hepr.12536. Epub 2015 Jun 8.
10
Inter-genotypic recombinant hepatitis C virus strains in Japan noted by discrepancies between immunoassay and sequencing.在日本,免疫测定和测序之间的差异表明存在基因型间重组丙型肝炎病毒株。
J Med Virol. 2012 Jul;84(7):1018-24. doi: 10.1002/jmv.23300.